MJoTAtalks

Dr Susanna's guide to

www.MJoTA.org
click here

www.MJoTAtalks.org click here

www.drsusanna.org click here



Dr Susanna loves the countries and the peoples of Africa
 
Bookmark and Share
Diabetes news from the American Diabetes Association

Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.

Latest Top (10) News
Clinical trials testing therapies for diabetes

Latest Top (10) News


A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: LY900014;   Drug: Insulin Lispro
Sponsor:   Eli Lilly and Company
Not yet recruiting - verified September 2017

Fri, 15 Sep 2017 12:00:00 EDT


A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Conditions:   Gastroparesis;   Diabetes Mellitus
Interventions:   Drug: Relamorelin;   Drug: Placebo
Sponsor:   Allergan
Not yet recruiting - verified September 2017

Thu, 14 Sep 2017 12:00:00 EDT


Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus.
Condition:   Diabetic Nephropathies
Intervention:   Device: Doppler ultrasonography
Sponsor:   Assiut University
Not yet recruiting - verified September 2017

Thu, 14 Sep 2017 12:00:00 EDT


Efficacy and Safety of Sotagliflozin Versus Placebo in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: sotagliflozin (SAR439954);   Drug: insulin glargine (HOE901);   Drug: Placebo
Sponsor:   Sanofi
Not yet recruiting - verified September 2017

Thu, 14 Sep 2017 12:00:00 EDT


Priming Exercise in Type 1 Diabetes
Condition:   Type 1 Diabetes Mellitus
Intervention:   Behavioral: Priming exercise
Sponsor:   Liverpool Hope University
Not yet recruiting - verified September 2017

Thu, 14 Sep 2017 12:00:00 EDT


Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT
Conditions:   Chronic Pancreatitis;   Insulin Dependent Diabetes
Interventions:   Drug: Hydroxychloroquine;   Drug: Placebo
Sponsors:   The Cleveland Clinic;   Allegheny Singer Research Institute;   Stanford University
Not yet recruiting - verified September 2017

Wed, 13 Sep 2017 12:00:00 EDT


ZIMBA: Clinical Trial in Paediatric Obesity
Conditions:   Obesity, Childhood;   Insulin Resistance;   Zinc Deficiency;   Inositol
Interventions:   Dietary Supplement: Zinc and Myo-inositol;   Drug: Placebos
Sponsor:   Azienda Ospedaliero Universitaria Maggiore della Carita
Not yet recruiting - verified September 2017

Wed, 13 Sep 2017 12:00:00 EDT


Beta Adrenergic Antagonist for the Healing of Chronic DFU
Conditions:   Chronic Diabetic Foot Ulcers;   Diabetic Neuropathic Ulcers;   Non Healing Wound
Interventions:   Drug: Timolol;   Drug: Non biologically active gel
Sponsors:   VA Office of Research and Development;   VA Northern California Health Care System
Not yet recruiting - verified September 2017

Tue, 12 Sep 2017 12:00:00 EDT


Incretin and CRTd.
Conditions:   Type 2 Diabetes Mellitus;   Heart Failure
Interventions:   Drug: Incretin Effect;   Device: Cardiac Resynchronization therapy defibrillator device
Sponsor:   University of Campania "Luigi Vanvitelli"
Completed - verified September 2017

Tue, 12 Sep 2017 12:00:00 EDT


Protein Intake and Step Reduction in Older Adults
Conditions:   Aging;   Muscle Loss
Interventions:   Dietary Supplement: Whey;   Dietary Supplement: Collagen
Sponsors:   McMaster University;   National Dairy Council
Active, not recruiting - verified September 2017

Tue, 12 Sep 2017 12:00:00 EDT
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms
Statement from FDA Commissioner Scott Gottlieb, M.D., about crops impacted by Hurricanes Harvey and Irma and FDA’s work with farmers affected by the storms

Thu, 14 Sep 2017 13:48:00 -0400


FDA approves new treatment for adults with relapsed follicular lymphoma
The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.

Thu, 14 Sep 2017 12:56:00 -0400


FDA approves first biosimilar for the treatment of cancer
The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.

Thu, 14 Sep 2017 12:11:00 -0400


FDA permits marketing of mobile medical application for substance use disorder
Today, the U.S. Food and Drug Administration permitted marketing of the first mobile medical application to help treat substance use disorders (SUD). The Reset application is intended to be used with outpatient therapy to treat alcohol, cocaine, marijuana and stimulant SUDs. The application is not intended to be used to treat opioid dependence.

Thu, 14 Sep 2017 11:16:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy
Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy

Thu, 07 Sep 2017 12:32:00 -0400


FDA clears mammography device with option for patient-assisted compression
Today, the U.S. Food and Drug Administration cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram x-ray is taken.

Fri, 01 Sep 2017 15:07:00 -0400


FDA approves Mylotarg for treatment of acute myeloid leukemia
The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also approved Mylotarg for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who have not responded to initial treatment (refractory).

Fri, 01 Sep 2017 11:19:00 -0400


Statement from Center for Drug Evaluation and Research Director Janet Woodcock regarding safety concerns related to investigational use of Keytruda in multiple myeloma
Statement from Center for Drug Evaluation and Research Director Janet Woodcock regarding safety concerns related to investigational use of Keytruda in multiple myeloma

Thu, 31 Aug 2017 11:08:00 -0400


FDA approval brings first gene therapy to the United States
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

Wed, 30 Aug 2017 10:41:00 -0400


FDA approves new antibacterial drug
The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.

Tue, 29 Aug 2017 17:56:00 -0400